[Translation] Phase I clinical study comparing the pharmacokinetics and safety of the experimental drug liraglutide injection and the reference drug Novoli® in Chinese healthy male subjects
主要目的:比对试验药物利拉鲁肽注射液与对照药物诺和力®在中国健康男性受试者中单次皮下注射给药的主要药代动力学(PK)参数,评价两药物的生物等效性。
次要目的:评价试验药物利拉鲁肽注射液与对照药物诺和力®在中国健康男性受试者中单次皮下注射给药的安全性。
[Translation] Main purpose: To compare the main pharmacokinetic (PK) parameters of the test drug liraglutide injection and the control drug Novoli® in Chinese healthy male subjects by a single subcutaneous injection, and to evaluate the biological properties of the two drugs. Equivalence.
Secondary objective: To evaluate the safety of the test drug liraglutide injection and the control drug Novoli® in a single subcutaneous injection in healthy Chinese male subjects.